Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
Presentation TCT 2024 TCT 813: Long-Term Outcomes of Dapagliflozin in Acute Myocardial Infarction and Preserved Ejection Fraction Presenter: Bu-Yuan Hsiao October 29, 2024
Presentation TCT 2024 TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR) Presenter: Bruce Adrian Casipit October 29, 2024
Presentation TCT 2024 TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies Presenter: Brian Potter October 28, 2024
Presentation NY Valves 2024 The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial Presenter: Lauren Sharan Ranard June 07, 2024
Presentation NY Valves 2024 Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data Presenter: Omar M. Abdelfattah June 07, 2024
Presentation NY Valves 2024 Impact of Baseline Left Ventricular Ejection Fraction on Outcomes in Women Undergoing Transcatheter Aortic Valve Replacement: Insights From the WIN-TAVI Registry Presenter: Francesca Maria Di Muro June 06, 2024
Presentation NY Valves 2024 Predictors and Clinical Impact of Worsening Left Ventricular Ejection Fraction After Mitral Transcatheter Edge-to-Edge Repair Presenter: Sachiyo Ono June 05, 2024
Presentation NY Valves 2024 Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30% Presenter: Eduardo A. Arias June 05, 2024
Presentation THT 2024 The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions Presenter: Kevin Makati March 05, 2024
Presentation THT Abstracts 2024 Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF) Presenter: Alexandra Steverson March 05, 2024
Presentation THT 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results Presenter: Sanjiv J. Shah March 05, 2024
Presentation THT Abstracts 2024 Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction Presenter: Joseph Maenza March 04, 2024
Presentation THT Abstracts 2024 Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF) Presenter: Amish Raval March 04, 2024
Presentation THT Abstracts 2024 Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics Presenter: Nadira Hamid March 04, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF Presenter: Sheldon Litwin March 04, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis † Presenter: Marat Fudim March 04, 2024
Presentation THT 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF Presenter: Sheldon E. Litwin March 04, 2024
Presentation THT 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis Presenter: Marat Fudim March 04, 2024
Presentation THT 2024 Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics Presenter: Nadira Hamid March 04, 2024